Decheng Capital »

4d Molecular Therapeutics In shares owned by Decheng Capital

Quarter-by-quarter ownership of 4d Molecular Therapeutics In (FDMT) shares owned by Decheng Capital from 13F filings

Historical chart of Decheng Capital investment in 4d Molecular Therapeutics In

Tip: Access up to 7 years of quarterly data

All positions including 4d Molecular Therapeutics In held by Decheng Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in 4d Molecular Therapeutics In by Decheng Capital

Quarter filed Position value Share count Share price at filing
2024-09-30 $4.3M 398k 10.81
2024-06-30 $7.3M 348k 20.99
2024-03-31 $11M 348k 31.86